PROTAC TG2 Degrader-1 (Compound 11) is a VHL-based PROTAC that targets tissue transglutaminase (TG2) and exhibits a binding affinity with a K D of 68.9 µM. This compound effectively decreases TG2 levels in ovarian cancer cells through a proteasome-dependent pathway.
Molecular Weight:
1052.29
Formula:
C55H73N9O10S
Target:
PROTACs
* VAT and and shipping costs not included. Errors and price changes excepted
